1,303
Views
67
CrossRef citations to date
0
Altmetric
Disease of the Year

Epidemiology of Ocular Toxoplasmosis

, MD, , PhD & , MD
Pages 68-75 | Received 18 Dec 2011, Accepted 23 Jan 2012, Published online: 12 Mar 2012

REFERENCES

  • Wakefield D, Dunlop I, McCluskey PJ, et al. Uveitis: aetiology and disease associations in an Australian population. Aust N Z J Ophthalmol. 1986;14:181–187.
  • Brezin A, Cisneros B. Congenital and acquired infection in ocular toxoplasmosis. Invest Ophthalmol Vis Sci. 1999;40:S383.
  • Päivönsalo-Hietanen T, Tuominen J, Vaahtoranta-Lehtonen H, et al. Incidence and prevalence of different uveitis entities in Finland. Acta Ophthalmol Scand. 1997;75:76–81.
  • Friedmann CT, Knox DL. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol. 1969;81:481–493.
  • Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol. 2003;136:973–988.
  • Dodds EM, Holland GN, Stanford MR, et al.; International Ocular Toxoplasmosis Research Group. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol. 2008;146:856–65.e2.
  • Holland GN. Ocular toxoplasmosis: the influence of patient age. Mem Inst Oswaldo Cruz. 2009;104:351–357.
  • Nguyen AM, Sève P, Le Scanff J, et al. Clinical and etiological aspects of uveitis: a retrospective study of 121 patients referred to a tertiary centre of ophthalmology. Rev Med Interne. 2011;32:9–16.
  • Accorinti M, Bruscolini A, Pirraglia MP, et al. Toxoplasmic retinochoroiditis in an Italian referral center. Eur J Ophthalmol. 2009;19:824–830.
  • Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. 1992;114:136–144.
  • Gilbert RE, Stanford MR. Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol. 2000;84:224–226.
  • Guerina NG, Hsu HW, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med. 1994;330:1858–1863.
  • Conyn-van-Spaedonck MAE. Prevention of Congenital Toxoplasmosis in the Netherlands (Thesis). Netherlands: National Institute of Public Health and Environmental Protection; 1991.
  • Lappalainen M, Koskiniemi M, Hiilesmaa V, et al. Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. The Study Group. Pediatr Infect Dis J. 1995;14:354–361.
  • Schmidt DR, Hogh B, Andersen O, et al. The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002. Arch Dis Child. 2006;91:661–665.
  • Berrébi A, Assouline C, Bessières MH, et al. Long-term outcome of children with congenital toxoplasmosis. Am J Obstet Gynecol. 2010;203:552.e1–552.e6.
  • Mets MB, Holfels E, Boyer KM, et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol. 1996;122:309–324.
  • Peyron F, Wallon M, Bernardoux C. Long-term follow-up of patients with congenital ocular toxoplasmosis. N Engl J Med. 1996;334:993–994.
  • Couvreur J, Desmonts G, Aron-Rosa D. Le prognostic oculaire de la toxoplasmose congenitale: role du traitement: communication preliminaire. Ann Pediatr (Paris). 1984;31:855–858.
  • Gras L, Wallon M, Pollak A, et al.; European Multicenter Study on Congenital Toxoplasmosis. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr. 2005;94:1721–1731.
  • , SYROCOT (Systematic Review on Congenital Toxoplasmosis) study groupThiébaut R, Leproust S, Chêne G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet. 2007;369:115–122.
  • Freeman K, Tan HK, Prusa A, et al.; European Multicentre Study on Congenital Toxoplasmosis. Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study. Pediatrics. 2008;121:e1215–e1222.
  • Rothova A. Ocular involvement in toxoplasmosis. Br J Ophthalmol. 1993;77:371–377.
  • Couvreur J, Thulliez P. Acquired toxoplasmosis of ocular or neurologic site: 49 cases. Presse Med. 1996;25:438–442.
  • Leblanc A, Bamberger J, Guillien F, et al. Acquired toxoplasmic chorioretinitis with a late onset. Arch Fr Pediatr. 1985;42:37–39.
  • Burnett AJ, Shortt SG, Isaac-Renton J, et al. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology. 1998;105:1032–1037.
  • Bowie WR, King AS, Werker DH, et al. Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet. 1997;350:173–177.
  • Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, et al. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology. 2002;109:869–878.
  • Kemmeren JM, Mangen M-JJ, Van Duynhoven YTHP, et al. Priority setting of foodborne pathogens—disease burden and costs of selected enteric pathogens. Report no. 330080001. Bilthoven: National Institute for Public Health and the Environment; 2006.
  • Kortbeek LM, Hofhuis A, Nijhuis CD, et al. Congenital toxoplasmosis and DALYs in the Netherlands. Mem Inst Oswaldo Cruz. 2009;104:370–373.
  • Havelaar AH, Kemmeren JM, Kortbeek LM. Disease burden of congenital toxoplasmosis. Clin Infect Dis. 2007;44:1467–1474.
  • Bahia-Oliveira LM, Jones JL, Azevedo-Silva J, et al. Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerging Infect Dis. 2003;9:55–62.
  • de Moura L, Bahia-Oliveira LM, Wada MY, et al. Waterborne toxoplasmosis, Brazil, from field to gene. Emerging Infect Dis. 2006;12:326–329.
  • Palanisamy M, Madhavan B, Balasundaram MB, et al. Outbreak of ocular toxoplasmosis in Coimbatore, India. Indian J Ophthalmol. 2006;54:129–131.
  • Holland GN. An epidemic of toxoplasmosis: lessons from Coimbatore, India. Arch Ophthalmol. 2010;128:126–128.
  • Dubey JP. Toxoplasmosis—a waterborne zoonosis. Vet Parasitol. 2004;126:57–72.
  • Su C, Evans D, Cole RH, et al. Recent expansion of Toxoplasma through enhanced oral transmission. Science. 2003;299:414–416.
  • Evengård B, Petersson K, Engman ML, et al. Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect. 2001;127:121–127.
  • Jenum PA, Stray-Pedersen B. Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women. J Clin Microbiol. 1998;36:2907–2913.
  • Forsgren M, Gille E, Ljungström I, Nokes DJ. Toxoplasma gondii antibodies in pregnant women in Stockholm in 1969, 1979, and 1987. Lancet. 1991;337:1413–1414.
  • Berger F, Goulet V, Le Strat Y, Desenclos JC. Toxoplasmosis among pregnant women in France: risk factors and change of prevalence between 1995 and 2003. Rev Epidemiol Sante Publique. 2009;57:241–248.
  • Villena I, Ancelle T, Delmas C, et al.; and the Toxosurv Network and National Reference Centre for Toxoplasmosis. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill. 2010;15:19600.
  • Garweg JG, Scherrer JN, Halberstadt M. Recurrence characteristics in European patients with ocular toxoplasmosis. Br J Ophthalmol. 2008;92:1253–1256.
  • Gilbert RE, Dunn DT, Lightman S, et al. Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect. 1999;123:283–289.
  • Hofhuis A, van Pelt W, van Duynhoven YT, et al. Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/1996 and 2006/2007. Epidemiol Infect. 2011;139:530–538.
  • Tugal-Tutkun I, Corum I, Otük B, et al. Active ocular toxoplasmosis in Turkish patients: a report on 109 cases. Int Ophthalmol. 2005;26:221–228.
  • Dolkh TI, Zaparil NS, Kadtsyna TV, et al. Epidemiologival and clinocoimmunological monitoring of toxoplasmosis in the Omsk region. Med Parazitol (Mosk) 2008;1:19–22.
  • Jones JL, Kruszon-Moran D, Sanders-Lewis K, et al. Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade. Am J Trop Med Hyg. 2007;77:405–410.
  • Jones JL, Dargelas V, Roberts J, et al. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis. 2009;49:878–884.
  • Dubey JP, Hill DE, Jones JL, et al. Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers. J Parasitol. 2005;91:1082–1093.
  • Jones JL, Holland GN. Annual burden of ocular toxoplasmosis in the US. Am J Trop Med Hyg. 2010;82:464–465.
  • Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol. 1973;57:1–17.
  • Aramini JJ, Stephen C, Dubey JP. Toxoplasma gondii in Vancouver Island cougars (Felis concolor vancouverensis): serology and oocyst shedding. J Parasitol. 1998;84:438–440.
  • Dias RA, Navarro IT, Ruffolo BB, et al. Toxoplasma gondii in fresh pork sausage and seroprevalence in butchers from factories in Londrina, Paraná State, Brazil. Rev Inst Med Trop Sao Paulo. 2005;47:185–189.
  • Jones JL, Lopez B, Alvarez Mury M, et al. Toxoplasma gondii infection in rural Guatemalan children. Am J Trop Med Hyg. 2005;72:295–300.
  • Chacin-Bonilla L, Sanchez-Chavez Y, Monsalve F, et al. Seroepidemiology of toxoplasmosis in amerindians from western Venezuela. Am J Trop Med Hyg. 2001;65:131–135.
  • Melamed J. Titulos dos anticorpos especificos na toxoplasmosie ocular. Arq Bras Ophtalmol. 1982;45:87–90.
  • Melamed J. Peculiaridades da toxoplasmose ocular no Rio Grande do Sul. Arq Bras Oftalmol. 1988;51:197–200.
  • Melamed J. Contributions to the history of ocular toxoplasmosis in Southern Brazil. Mem Inst Oswaldo Cruz. 2009;104:358–363.
  • Khan A, Jordan C, Muccioli C, et al. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerging Infect Dis. 2006;12:942–949.
  • Belfort-Neto R, Nussenblatt V, Rizzo L, et al. High prevalence of unusual genotypes of Toxoplasma gondii infection in pork meat samples from Erechim, Southern Brazil. An Acad Bras Cienc. 2007;79:111–114.
  • Silveira C, Belfort R Jr, Burnier M Jr, et al. Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol. 1988;106:362–364.
  • Matos K, Muccioli C, Belfort R Jr, et al. Correlation between clinical diagnosis and PCR analysis of serum, aqueous, and vitreous samples in patients with inflammatory eye disease. Arq Bras Oftalmol. 2007;70:109–114.
  • de Amorim Garcia CA, Oréfice F, de Oliveira Lyra C, et al. Socioeconomic conditions as determining factors in the prevalence of systemic and ocular toxoplasmosis in Northeastern Brazil. Ophthalmic Epidemiol. 2004;11:301–317.
  • Silveira C, Belfort R Jr, Muccioli C, et al. A follow-up study of Toxoplasma gondii infection in southern Brazil. Am J Ophthalmol. 2001;131:351–354.
  • Torre A de-la, González G, Díaz-Ramirez J, Gómez-Marín JE. Screening by ophthalmoscopy for Toxoplasma retinochoroiditis in Colombia. Am J Ophthalmol. 2007;143:354–356.
  • Torre A de-la, López-Castillo CA, Gómez-Marín JE. Incidence and clinical characteristics in a Colombian cohort of ocular toxoplasmosis. Eye (Lond). 2009;23:1090–1093.
  • Grigg ME, Ganatra J, Boothroyd JC, et al. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis. 2001;184:633–639.
  • Vallochi AL, Muccioli C, Martins MC, et al. The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil. Am J Ophthalmol. 2005;139:350–351.
  • Ajzenberg D, Collinet F, Mercier A, et al. Genotyping of Toxoplasma gondii isolates with 15 microsatellite markers in a single multiplex PCR assay. J Clin Microbiol. 2010;48:4641–4645.
  • Vasconcelos-Santos DV, Machado Azevedo DO, Campos WR, et al.; and the UFMG Congenital Toxoplasmosis Brazilian Group. Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology. 2009;116:2199–2205.
  • Silva CS, Neves Ede S, Benchimol EI, et al. Postnatal acquired toxoplasmosis patients in an infectious diseases reference center. Braz J Infect Dis. 2008;12:438–441.
  • Gilbert RE, Freeman K, Lago EG, et al.; European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008;2:e277.
  • Carme B, Demar M, Ajzenberg D, et al. Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerging Infect Dis. 2009;15:656–658.
  • Song KJ, Shin JC, Shin HJ, et al. Seroprevalence of toxoplasmosis in Korean pregnant women. Korean J Parasitol. 2005;43:69–71.
  • Hung CC, Chen MY, Hsieh SM, et al. Prevalence of Toxoplasma gondii infection and incidence of toxoplasma encephalitis in non-haemophiliac HIV-1-infected adults in Taiwan. Int J STD AIDS. 2005;16:302–306.
  • Singh S, Pandit AJ. Incidence and prevalence of toxoplasmosis in Indian pregnant women: a prospective study. Am J Reprod Immunol. 2004;52:276–283.
  • Nissapatorn V, Lee C, Quek KF, Leong CL, Mahmud R, Abdullah KA. Toxoplasmosis in HIV/AIDS patients: a current situation. Jpn J Infect Dis. 2004;57:160–165.
  • Nissapatorn V, Suwanrath C, Sawangjaroen N, et al. Toxoplasmosis-serological evidence and associated risk factors among pregnant women in southern Thailand. Am J Trop Med Hyg. 2011;85:243–247.
  • Nissapatorn V, Abdullah KA. Review on human toxoplasmosis in Malaysia: the past, present and prospective future. Southeast Asian J Trop Med Public Health. 2004;35:24–30.
  • Wang YH. Endogenous posterior uveitis and toxoplasma infection: a case-control study [Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 1991;12:29–32.
  • Yang P, Zhang Z, Zhou H, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005;30:943–948.
  • Balasundaram MB, Andavar R, Palaniswamy M, et al. Outbreak of acquired ocular toxoplasmosis involving 248 patients. Arch Ophthalmol. 2010;128:28–32. Erratum in: Arch Ophthalmol. 2010;128:508.
  • Elhence P, Agarwal P, Prasad KN, et al. Seroprevalence of Toxoplasma gondii antibodies in North Indian blood donors: implications for transfusion transmissible toxoplasmosis. Transfus Apher Sci. 2010;43:37–40.
  • Khurana S, Bagga R, Aggarwal A, et al. Serological screening for antenatal toxoplasma infection in India. Indian J Med Microbiol. 2010;28:143–146.
  • Suhardjo, Utomo PT, Agni AN. Clinical manifestations of ocular toxoplasmosis in Yogyakarta, Indonesia: a clinical review of 173 cases. Southeast Asian J Trop Med Public Health. 2003;34:291–297.
  • Pathanapitoon K, Kunavisarut P, Ausayakhun S, et al. Uveitis in a tertiary ophthalmology centre in Thailand. Br J Ophthalmol. 2008;92:474–478.
  • Nissapatorn V, Lim YA, Jamaiah I, et al. Parasitic infections in Malaysia: changing and challenges. Southeast Asian J Trop Med Public Health. 2005;36Suppl 4:50–59.
  • Fan CK, Hung CC, Su KE, et al. Seroprevalence of Toxoplasma gondii infection among pre-schoolchildren aged 1-5 years in the Democratic Republic of Sao Tome and Principe, Western Africa. Trans R Soc Trop Med Hyg. 2006;100:446–449.
  • Elnahas A, Gerais AS, Elbashir MI, et al. Toxoplasmosis in pregnant Sudanese women. Saudi Med J. 2003;24:868–870.
  • Millogo A, Ki-Zerbo GA, Traoré W, et al. Toxoplasma serology in HIV infected patients and suspected cerebral toxoplasmosis at the Central Hospital of Bobo-Dioulasso (Burkina Faso). Bull Soc Pathol Exot. 2000;93:17–19.
  • Ronday MJ, Stilma JS, Barbe RF, et al. Aetiology of uveitis in Sierra Leone, west Africa. Br J Ophthalmol. 1996;80:956–961.
  • Ramos JM, Milla A, Rodríguez JC, et al. Seroprevalence of Toxoplasma gondii infection among immigrant and native pregnant women in Eastern Spain. Parasitol Res. 2011 May 4. [Epub ahead of print].
  • Swai ES, Schoonman L. Seroprevalence of Toxoplasma gondii infection amongst residents of Tanga district in north-east Tanzania. Tanzan J Health Res. 2009;11:205–209.
  • Ajzenberg D, Yera H, Marty P, et al. Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings. J Infect Dis. 2009;199:1155–1167.
  • Mercier A, Devillard S, Ngoubangoye B, et al. Additional haplogroups of Toxoplasma gondii out of Africa: population structure and mouse-virulence of strains from Gabon. PLoS Negl Trop Dis. 2010;4:e876.
  • Khairallah M, Yahia SB, Ladjimi A, et al. Pattern of uveitis in a referral centre in Tunisia, North Africa. Eye (Lond). 2007;21:33–39.
  • Al-Qassab S, Reichel MP, Su C, et al. Isolation of Toxoplasma gondii from the brain of a dog in Australia and its biological and molecular characterization. Vet Parasitol. 2009;164:335–339.
  • Parameswaran N, Thompson RC, Sundar N, et al. Non-archetypal Type II-like and atypical strains of Toxoplasma gondii infecting marsupials of Australia. Int J Parasitol. 2010;40:635–640.
  • Benenson MW, Takafuji ET, Lemon SM, et al. Oocyst-transmitted toxoplasmosis associated with ingestion of contaminated water. N Engl J Med. 1982;307:666–669.
  • Boyer K, Hill D, Mui E, et al. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin Infect Dis. 2011;53:1081–1089.
  • Teutsch SM, Juranek DD, Sulzer A, et al. Epidemic toxoplasmosis associated with infected cats. N Engl J Med. 1979;300:695–699.
  • Stagno S, Dykes AC, Amos CS, et al. An outbreak of toxoplasmosis linked to cats. Pediatrics. 1980;65:706–712.
  • Bobic B, Jevremovic I, Marinkovic J, et al. Risk factors for Toxoplasma infection in a reproductive age female population in the area of Belgrade, Yugoslavia. Eur J Epidemiol. 1998;14:605–610.
  • Kapperud G, Jenum PA, Stray-Pedersen B, et al. Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway. Am J Epidemiol. 1996;144:405–412.
  • Buffolano W, Gilbert RE, Holland FJ, et al. Risk factors for recent toxoplasma infection in pregnant women in Naples. Epidemiol Infect. 1996;116:347–351.
  • Baril L, Ancelle T. Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scand J Infect Dis. 1999;31:305–309.
  • Cook AJ, Gilbert RE, Buffolano W, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ. 2000;321:142–147.
  • Conyn-vanSpaedonck MA, van Knapen F. Choices in preventive strategies: experience with the prevention of congenital toxoplasmosis in The Netherlands. Scand J Infect Dis Suppl. 1992;84:51–58.
  • Lopez A, Dietz VJ. Preventing congenital toxoplasmosis. MMWR Recomm Rep. 2000;49:59–68.
  • Thiébaut R, Leroy V, Alioum A, et al. Biases in observational studies of the effect of prenatal treatment for congenital toxoplasmosis. Eur J Obstet Gynecol Reprod Biol. 2006;124:3–9.
  • Kijlstra A, Eissen OA, Cornelissen J, et al. Toxoplasma gondii infection in animal-friendly pig production systems. Invest Ophthalmol Vis Sci. 2004;45:3165–3169.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.